![]() Inhaled formoterol: maximum delivered dose of 54 micrograms over 24 hours.Inhaled salbutamol: maximum 1600 micrograms over 24 hours in divided doses not to exceed 600 micrograms over 8 hours starting from any dose.Vascular endothelial growth factor (VEGF)Īnd other growth factors or growth factor modulators affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilization, regenerative capacity or fibre type switching.Īll prohibited substances in this class are Specified Substances.Īll selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. ![]() ![]() Insulin-like growth factor 1 (IGF-1) and its analogues.GROWTH FACTORS AND GROWTH FACTOR MODULATORS growth hormone secretagogues (GHS) and their mimetics.CJC-1293, CJC-1295, sermorelin and tesamorelin) growth hormone-releasing hormone (GHRH) and its analogues (e.g.AOD-9604 and hGH 176-191Ģ.4 GROWTH HORMONE RELEASING FACTORS, INCLUDING, BUT NOT LIMITED TO: lonapegsomatropin, somapacitan and somatrogon PEPTIDE HORMONES AND THEIR RELEASING FACTORSĢ.1 CHORIONIC GONADOTROPHIN (CG) AND LUTEINIZING HORMONE (LH) AND THEIR RELEASING FACTORS IN MALES, E.G.Ģ.2 CORTICOTROPHINS AND THEIR RELEASING FACTORS, E.G.Ģ.3 GROWTH HORMONE (GH), ITS ANALOGUES AND FRAGMENTS, INCLUDING, BUT NOT LIMITED TO: CNTO-530, peginesatide)ġ.2 HYPOXIA-INDUCIBLE FACTOR (HIF) ACTIVATING AGENTS, E.G.ġ.4 TRANSFORMING GROWTH FACTOR -BETA (TGF-Β) SIGNALING INHIBITORS, E.G.ġ.5 INNATE REPAIR RECEPTOR AGONISTS, E.G.Ģ. EPO-mimetic agents and their constructs (e.g.ERYTHROPOIETINS (EPO) AND AGENTS AFFECTING ERYTHROPOIESIS, INCLUDING, BUT NOT LIMITED TO:ġ.1 ERYTHROPOIETIN-RECEPTOR AGONISTS, E.G. The following substances, and other substances with similar chemical structure or similar biological effect(s), are prohibited:ġ. Selective androgen receptor modulators Īll prohibited substances in this class are non -Specified Substances.Trenbolone (17β-hydroxyestr-4,9,11-trien-3- one)Īnd other substances with a similar chemical structure or similar biological effect(s).Prostanozol (17β-1’H-pyrazolo-5α-androstane).Prasterone (dehydroepiandrosterone, DHEA, 3β-hydroxyandrost-5-en-17-one).Metribolone (methyltrienolone, 17β-hydroxy- 17α-methylestra-4,9,11-trien-3-one).Methylnortestosterone (17β-hydroxy-17α- methylestr-4-en-3-one).Furazabol (17α-methyl oxadiazolo-5α-androstan-17β-ol).Epi-dihydrotestosterone (17β-hydroxy-5β- androstan-3-one).Epiandrosterone (3β-hydroxy-5α-androstan- 17-one).Dehydrochlormethyltestosterone (4-chloro- 17β-hydroxy-17α-methylandrosta-1,4-dien- 3-one).Androstenedione (androst-4-ene-3,17- dione).Androstenediol (androst-5-ene-3β,17β-diol).Androstanolone (5α-dihydrotestosterone, 17β-hydroxy-5α-androstan-3-one).Androst-4-ene-3,11,17-trione (11-ketoandrostenedione, adrenosterone).5-Androstenedione (androst-5-ene-3,17- dione).4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one).WHEN ADMINISTERED EXOGENOUSLY, INCLUDING BUT NOT LIMITED TO: Legal Opinions and Articles on the CodeĪll prohibited substances in this class are non- Specified Substances.Global Learning and Development Framework.Social Science Research Collaboration Platform.How does an organization implement the Code and maintain Code compliance?.
0 Comments
Leave a Reply. |